Skip to main content
Clinical Trials/NCT05158530
NCT05158530
Completed
Not Applicable

Effect Of Exercise Training In Patients With Lung Cancer During Chemotherapy Treatment

Riphah International University1 site in 1 country40 target enrollmentDecember 20, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer, Nonsmall Cell
Sponsor
Riphah International University
Enrollment
40
Locations
1
Primary Endpoint
6 min walk test: Distance (meters)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

To determine the effects of exercise training in patients with lung cancer during chemotherapy treatment. In currently accessible literature, majority studies, met-analysis, and systemic reviews are related to surgical procedures and post-op pulmonary Rehabilitation of patients with Lung cancer. In literature, Gap related to the control group was observed also. The current study aimed to fulfill this gap by planning a structured intervention plan for the control group as well. It will also add in literature the deficiency of oncology rehab for patients receiving chemotherapy only.

Detailed Description

Literature suggested that a pulmonary rehabilitation program for patients with non-small cell lung cancer undergoing induction chemo-radiotherapy seems to improve respiratory function. It is particularly recommended for smokers and patients with respiratory impairment.

Registry
clinicaltrials.gov
Start Date
December 20, 2021
End Date
April 1, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed patients of stage 1 and 2 Non-small cell lung carcinoma (NSCLC) including Adenocarcinoma \& squamous cell carcinoma The diagnosis was established within 6 wk prior to enrollment and was confirmed by histology.
  • Participants are undergoing lung cancer chemotherapy Participant has the willingness to participate in training WHO physical fitness scores 0-1 Able to perform 6-minute walk test (6MWT) at baseline

Exclusion Criteria

  • • Participant with history of trauma and surgery
  • Patients with lung disease other than lung cancer
  • Uncontrolled hypertension or unstable coronary artery disease.
  • Severe OA, bone or CNS metastases.
  • hemoglobin \<10 g/dL
  • Lower than 3,500 white blood cells per microliter of blood

Outcomes

Primary Outcomes

6 min walk test: Distance (meters)

Time Frame: 4 weeks

Changes from the baseline, 6 min walk test (6 MWT) was used to measure Functional capacity. It is a sub maximal exercise test which can aid in assessing functional capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters which an individual covers in 6 min without any support.

Forced Expiratory Volume in 1 second (FEV1)

Time Frame: 4 weeks

Changes from the Baseline, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters

Forced vital Capacity (FVC)

Time Frame: 4 weeks

Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters

Rate of perceived exertion (RPE)

Time Frame: 4 weeks

Changes From the Baseline, measured through Borg RPE scale which measures a person's perception of their effort and exertion breathlessness, and fatigue during physical work rating between 1 and 10. The higher the number, the more intense the exercise. An RPE of 1 is often referred to as just above rest, hardly any exertion, while an RPE of 10 is a maximal effort.

Secondary Outcomes

  • Hospital Anxiety and Depression(4 weeks)
  • Mindfulness(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials